Croup: Diagnosis and Management

Area of Science:

• Pediatrics
• Respiratory Medicine
• Emergency Medicine

Background:

• Croup is a common respiratory illness in young children, characterized by upper airway obstruction, inspiratory stridor, and a barking cough.
• It affects approximately 3% of children aged six months to three years and contributes significantly to pediatric hospitalizations for respiratory illnesses.
• While often associated with fever, it's not a required diagnostic criterion, and laboratory or imaging studies are rarely necessary.

Purpose of the Study:

• To review the current understanding and management of croup in pediatric patients.
• To evaluate the efficacy of dexamethasone and nebulized epinephrine in treating croup symptoms and outcomes.
• To provide evidence-based recommendations for the diagnosis and treatment of croup.

Main Methods:

• Review of randomized controlled trials and clinical studies on croup management.
• Analysis of treatment outcomes including symptom improvement, return visits, and hospitalization duration.
• Focus on pharmacological interventions such as corticosteroids and epinephrine.

Main Results:

• A single dose of dexamethasone (oral, intramuscular, or intravenous) significantly improves croup symptoms and reduces hospital length of stay and return visits across all severity levels.
• For moderate to severe croup, adding nebulized epinephrine to dexamethasone further enhances symptom relief and shortens hospitalization.
• Diagnostic workup typically does not require laboratory tests, viral cultures, or routine imaging, reserving these for suspected alternative diagnoses.

Conclusions:

• Dexamethasone is a highly effective monotherapy for croup of any severity in children.
• Nebulized epinephrine provides additional benefit for moderate to severe croup cases.
• Current evidence supports conservative diagnostic approaches and targeted pharmacological interventions for optimal croup management.